Navigation Links
AlphaPette Pipettor - Range 1000l - 5000l

ProductsAlphaPette Pipettor - Range 1000l - 5000l
Company MIDSCI
Item AlphaPette Pipettor - Range 1000l - 5000l
Features 
Description The AlphaPette Pipettor is the #1 Pipettor for sub-microliter pipetting and beyond. Offers accuracy, comfort, and reliability. Continuously adjustable. Features lPLUS, a direct-drive digital volume readout sub-micrometer. Easy interchangeable ejector buttons to fit large hands or tiny hands. Adjustable rapid pipet tip ejector with three different lengths. Air-displacement mechanism. No routine maintenance. Certified calibration. Ergonomically designed for comfort. Comes with a lifetime warranty!
Info MIDSCI
Customer Service: (800) 227-9997
Web site: http://www.midsci.com

Related medicine products :

1. AlphaPette Pipettor - Range 100l - 1000l
2. AlphaPette Pipettor - Range 20l - 200l
3. AlphaPette Pipettor - Range 2l - 20l
4. AlphaPette Pipettor - Range 0.5l - 10l
5. AlphaPette Pipettor - Range 10l - 100l
6. AlphaPette Pipettor - Range 0.1l - 2l
7. Apricot Personal Pipettor
8. Aquarius 96 Multichannel Pipettor
9. Aquarius 384 Multichannel Pipettor
10. Cartesian Pipettor
11. AlphaForce Pipettor
0.3 mm hook angled 45 degrees, 9 mm from tip to bend. Flat smooth handle with polished finish. Overall length: 4.6 inches.
2.0 mm cup. Angled 45 degree shaft 8 mm from tip to bend with flat handle and polished finish. Overall length: 4.8 inches.
Round, knurled handle with polished finish and straight shaft. 1 mm ring curette 1.5 mm high, 33 mm shaft. Overall length: 5.1 inches.
0.5 mm curette cup, reverse side of sandblasted to polish capsule. Round knurled handle with polished finish. Overall length: 5 inches.
Medicine Products:
(Date:9/5/2008)...USTON - Lung cancer risk prediction models are enh...and by measuring DNA repair capacity, according to...ersity of Texas M. D. Anderson Cancer Center in tw...issue of Cancer Prevention Research . , In the ...hers found unique results based on increased expos...
(Date:9/4/2008)...New York, NY, September 5, 2008Private Medicare Ad...rcent more per enrollee in 2008 compared to what t...l Medicare fee-for-service program, according to a...he payment reductions to MA plans mandated by the ...ct of 2008 (MIPPA) scheduled to take effect begin...
(Date:9/4/2008)...ings of 3 studies focus on brain and pancreatic tu...ws) -- Potentially groundbreaking discoveries invo...he brain cancer glioblastoma and pancreatic cancer...earchers say. , "These studies represent the m... type and provide a detailed genetic map of these ...
(Date:9/4/2008)...PACIFIC PALISADES, Calif., Sept. 4 /PRNewswire/ --...recognized authority in the field of weight,contro...s Who in,California," "Who,s Who in The West," "Wh...o,s Who in Medicine and Health Care" and other hon...his expertise to exposing the,inaccurate, misleadi...
Breaking Medicine News(10 mins):Health News:Creating lung cancer risk models for specific populations refines prediction 2Health News:Creating lung cancer risk models for specific populations refines prediction 3Health News:Extra payments to Medicare Advantage plans to total $8.5 billion in 2008 2Health News:Genetic Mutations Linked to Deadly Cancers 2Health News:Genetic Mutations Linked to Deadly Cancers 3Health News:Genetic Mutations Linked to Deadly Cancers 4Health News:Phone World-famed Martin Schiff, M.D., at 310-454-6172 for Free Weight Loss 'No Diet, No Stuff' Method. Hates Diets, Loves to Have People Help Themselves 2
...ople in the United States are on waiting lists for... death of a matching donor, but more and more peop...t year nearly 7,000 people donated a kidney, segme...elp someone in need of a transplant. In fact at so...
...diabetics in China is smaller than that of many ot...na had around 23.8 million diabetics// of age betw...tween 40 and 59 are increasing in China, while dia...9 in developed countries," said Guo Xiaohui,who he...
...s the fourth leading cause of cancer deaths in the...ually affected // It is one of the most deadly ca...it has spread to other parts. Only about five perc...atients survive the first five years after being d...
...esting based on the ‘survival of the fittest’ theo...th a motive to nurture// the healthy ones, has bor...Couple, the first in UK, after successfully employ... This method proved a blessing to the parents in ...
Other Medicine News:Health News:Researchers Study Reimbursing Living Organ Donors for Out-of-Pocket Expenses 2Health News:Researchers Study Reimbursing Living Organ Donors for Out-of-Pocket Expenses 3
(Date:9/4/2008)... 4 /- Southern Research Institute,tod...h (NIH) has selected,the organization to participa...roduction Center Network (MLPCN). The MLPCN -- a c...lecular Libraries Program which is,designed to ben... the human,genome and validate future targets for ...
(Date:9/4/2008)...ent Identification for Targeted Therapies ...t HUNTINGTON BEACH, Calif., and AMSTERDAM, Neth...leader in molecular cancer diagnostics,today anno...ic test that,allows physicians to quantitatively d...n receptor (ER), progesterone receptor (PR) and Hu...
(Date:9/3/2008)...heumatology Research and Education Foundation,s W...es in Detecting, Treating and ...- For the first time during its,unprecedented init...e,American College of Rheumatology Research and Ed...quired from research funded by the Within Our,Reac...
(Date:9/3/2008)... Multaq(R) (dronedarone) decreased the risk of,str...atrial flutter already adequately tre..., Sept. 3 /- The results of...tudy were presented today at,the clinical trial up...,congress 2008, in Munich, Germany. Previous resul...
Breaking Medicine Technology:Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 2Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 3Southern Research Institute Wins $14.7 Million NIH Award to Participate in Molecular Libraries Probe Production Center Network 4Agendia Launches TargetPrint(R) for Breast Cancer Patients 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 2Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 3Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 4Further Analysis From ATHENA Study Showed That Multaq(R) (dronedarone) Reduced the Risk of Stroke in Patients With Atrial Fibrillation 5Statement by Lance Armstrong on Cancer Diagnosis of Senator Kennedy 19933 1Educational Drive Cut Death Rate From Sepsis 19930 1Educational Drive Cut Death Rate From Sepsis 19930 2Study analyzed SYMBICORT in children with persistent asthma 19926 1Study analyzed SYMBICORT in children with persistent asthma 19926 2Study analyzed SYMBICORT in children with persistent asthma 19926 3Ambulatory Services of America Inc Announces Joint Venture With Denton Cancer Center LP 19922 1Ambulatory Services of America Inc Announces Joint Venture With Denton Cancer Center LP 19922 2
...ne Shows Strong Immune Response, Protection,Agains... 2007 /PRNewswire-FirstCall/ -- Novavax,Inc.,s vir... immune,response and provided protection against t...e- clinical data published in the online,edition o...ted in three animal models, including,the ferret, ...
...lif., April 03, 2007,/PRNewswire-FirstCall/ -- Cel...ults from its second multi-center Phase 2 trial of...uated escalating doses,of the immunotherapy in 80 ...te cancer (HRPC). Additional follow-up of,the 22 p...o that,being employed in the company,s ongoing Pha...
Other Medicine Technology:Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 2Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 3Novavax Vaccine Provides Robust Immune Response, Pre-Clinical Data,Show 4Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 2Cell Genesys Provides Final Median Survival Data From Second Phase,2 Trial of GVAX Immunotherapy for Prostate Cancer 3